Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

被引：5

作者：

不详

机构：

[1] Faculty of Medicine, University of British Columbia, Vancouver

[2] British Columbia Centre for Disease Control., British Columbia Cancer, Vancouver

[3] Lower Mainland Laboratories, British Columbia Cancer, Vancouver

[4] Cervical Cancer Screening Program, British Columbia Cancer, Vancouver

[5] Cancer Control Research, BC Cancer, Vancouver

[6] Canadian Centre for Applied Research in Cancer Control, Vancouver

[7] Faculty of Health Sciences, Simon Fraser University, Burnaby, BC

[8] Departments of Oncology and Epidemiology and Biostatistics, McGill University, Montreal, QC

来源：

OBSTETRICAL & GYNECOLOGICAL SURVEY | 2018年 / 73卷 / 11期

关键词：

D O I：

10.1097/OGX.0000000000000608

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

(Abstracted from JAMA 2018;320:43-52) There are only limited data in North American populations on the relative diagnostic effectiveness of cervical cancer screening with primary human papillomavirus (HPV) testing alone compared with cytology.

引用

页码：632 / 634

页数：3

共 50 条

[1] Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months The HPV FOCAL Randomized Clinical Trial
Ogilvie, Gina Suzanne
van Niekerk, Dirk
Krajden, Mel
Smith, Laurie W.
Cook, Darrel
Gondara, Lovedeep
Ceballos, Kathy
Quinlan, David
Lee, Marette
Martin, Ruth Elwood
Gentile, Laura
Peacock, Stuart
Stuart, Gavin C. E.
Franco, Eduardo L.
Coldman, Andrew J.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (01): : 43 - 52
[2] Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial (vol 320, pg 43, 2018)
Ogilvie, G. S.
van Niekerk, D.
Krajden, M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (21): : 2277 - 2277
[3] HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia
Giorgi-Rossi, Paolo
Franceschi, Silvia
Ronco, Guglielmo
[J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (06) : 1387 - 1394
[4] Clinical Significance of Testing Negative for HPV in Cervical Cytology with High-Grade Squamous Intraepithelial Lesion (HSIL)
Robison, Ariane
Allo, Ghassan
[J]. LABORATORY INVESTIGATION, 2019, 99
[5] Clinical Significance of Testing Negative for HPV in Cervical Cytology with High-Grade Squamous Intraepithelial Lesion (HSIL)
Robison, Ariane
Allo, Ghassan
[J]. MODERN PATHOLOGY, 2019, 32
[6] Adding HPV testing to cytology screening reduced ≥ grade 3 cervical intraepithelial neoplasia at 5 years
Budenholzer, Brian
[J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (02)
[7] HPV-NEGATIVE PAP SPECIMENS WITH HIGH-GRADE CERVICAL INTRAEPITHELIAL LESION OR CERVICAL CARCINOMA: POTENTIAL TO BE MISSED BY HPV TESTING AS PRIMARY CERVICAL CANCER SCREENING
Guo, M.
Zhou, H.
Khanna, A.
Sneige, N.
Staerkel, G.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 591 - 592
[8] ROLE OF CYTOLOGY AND HPV TESTING AFTER TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA
Andonova, I.
Iliev, N.
Zivkovic, N.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
[9] The role of HPV testing in patients with possible high-grade cervical cytology
Rao, Archana
Pather, Selvan
Dalrymple, Chris
Mackie, Adam
Deans, Rebecca
Carter, Jonathan
[J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (03) : 503 - 506
[10] HPV testing in management of cervical intraepithelial neoplasia (CIN)
Nobbenhuis, MAE
Walboomers, JMM
Helmerhorst, TJM
Rozendaal, L
Remmink, AJ
Voorhorst, FJ
Verheijen, RHM
Meijer, CJLM
[J]. EUROGIN 2000: 4TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS, 2000, : 135 - 136

← 1 2 3 4 5 →